ApprovalTrail

Approval · Notice of Compliance 11857 · 2010

TOLOXIN: Notice of Compliance 11857

Issued November 10, 2010

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
11857
Date
November 10, 2010
Company
Mm Therapeutics IncMontreal, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Admin
Reason
New dosage form
Therapeutic class
Cardiotonic glycoside

Products in this notice

BrandDINStatus today
TOLOXIN02242320Marketed

Medicinal ingredients